CAR-T cell therapiesTocilizumabCRSuniversity hospitalmultiorgan failure
…ty hospital is involved as a sponsor of clinical trials on both CAR-T cell therapies and bispecific antibodies (BsAbs), actively contributing to the…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,981–2,040 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Adaptive digital therapy1Adaptive radiotherapy1Adhesiolysis1Adjuvant External Beam Radiation Therapy1Adoptive CTL therapy1Adoptive T cell immunotherapy1Adoptive TIL therapy1Adoptive cell therapy (ACT)1Adoptive cell transfer-based immunotherapy1Adrenal surgery1Airway clearance techniques1Alcohol consumption1Allo-HCT1Allogeneic haematopoietic stem cell transplant1Allogeneic stem-cell transplant1Allogeneic stem-cell transplantation1Ambulatory consolidation therapy1Amputation1Anaesthetic management1Analgesic patch1Angioembolisation1Angioembolization1Ankle blocks1Anti-Aβ therapies1Anti-TNF α treatment1Anti-amyloid therapies1Anti-programmed cell death protein 1 (PD-1) antibody therapy1Anti-programmed cell death protein 1 (PD-1) immunotherapy1Antibiotic use271Antibody therapeutics1Anticonvulsant therapy41Antidiabetic treatment1Antihistamine therapy1Antiplatelet management1Antithrombotic treatment1Antithrombotic treatment strategy1Antituberculosis therapy1Apreo BREATHE Airway Scaffold1Arthroscopic shoulder surgery1Artisse intrasaccular device1At-home subcutaneous immunoglobulin treatment1Atez/Bev1Auricular vagal neuromodulation therapy1Auriculotemporal nerve block1Autologous CAR-T cell therapies1Autologous hamstring tendon grafts1Autologous hematopoietic stem cell transplant1Autologous tumor-infiltrating lymphocyte (TIL) therapy1B cell-targeted therapies1B-cell depleting biologic therapies1B-cell depleting treatment1B-cell targeted therapy1B7-H3-directed CAR T-cell therapy1BCAA supplementation1BCG therapy1BCMA-targeting CAR-T cell therapy1BEL1BEL-based triple therapy1BIC-based triple therapies1BLV1
Articles mentioning treatments
7,227 articles · page 390 of 603CAR-T cell therapyTocilizumabhaematologic malignanciesuniversity hospitalCRScorticosteroidscytokine release syndromemultiorgan failure
…strate the central role we play in this therapeutic innovation. CAR-T cell therapy is a major breakthrough in the management of haematologic malig…
ketogenic dietAicardi syndromevigabatrinperampanellevetiracetamhydrocortisonelamotriginefenfluraminevalproic acidtopiramate+2 more
…motrigine, valproic acid, vigabatrin, levetiracetam, primidone, ketogenic diet, rufinamide, topiramate, zonisamide, perampanel, and hydrocorti…
therapeutic anticoagulationaspirinVTEhaemorrhagecerebral accidents
…drug chart and administered at the correct time. With regard to therapeutic anticoagulation, statistical significance was found in the documentation of ind…
Oncology treatmentenzalutamideapalutamidepazopanibabirateroneolaparibsunitinibcapecitabineimatinibosimertinib+8 more
…Background and Importance Oncology treatment requires continuous monitoring and appropriate pharmacotherapeu…
Chimeric Antigen Receptor T-cell (CAR-T) therapyaxicabtagene ciloleuceltisagenlecleucelciltacabtagene autoleucelmultiple myelomaDLBCLanakinraacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANS+1 more
…Background and Importance Chimeric Antigen Receptor T-cell (CAR-T) therapy has improved outcomes in relapsed or refractory haematological …
Combination therapylinezolidceftazidime-avibactamcolistinoxazolidinonesnosocomial infectionsurinary tract infectionsmultidrug-resistant infections
…inly for respiratory (21.9%) and urinary tract infections (8%). Combination therapy was used in 26.7% of prescriptions, mainly for synergistic purp…
Immune checkpoint inhibitorspembrolizumabtertiary hospitalNSCLCmetastatic non-small-cell lung adenocarcinomaproton pump inhibitors
…Background and Importance Immune checkpoint inhibitors (ICI) have become a standard treatment in multiple malignancies…
DAPTaspiriniP2Y12chronic kidney diseaseacute myocardial infarctionatrial fibrillationdiabetes mellitustertiary hospitalNon-ST-segment Elevation Myocardial InfarctionST-segment elevation myocardial infarction+5 more
…in discharge treatment between men and women were observed (eg, DAPT and anticoagulation), these were not statistically significant.…
Therapeutic drug monitoringlinezolidamiodaroneclarithromycinamlodipinesevere infectionslevothyroxineRifampicinphenobarbital
…acokinetic variability may compromise both efficacy and safety. Therapeutic drug monitoring (TDM) can optimise dosing and reduce the risk of adverse effect…
CAR T-cell therapyECOG Performance StatusTisagenlecleucelKymriahhematologic malignanciesTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelmantle cell lymphoma+5 more
…pitalisation was 23.5 days (IQR 17-28).Conclusion and Relevance CAR T-cell therapy in real-world-practice achieves high early response rates, alth…
corticosteroid therapyipilimumablevofloxacinnivolumabprednisoneipilimumab/nivolumabamoxicillin–clavulanatelevetiracetamadvanced clear-cell renal carcinoma
…diated origin of hepatic and neurological alterations optimised corticosteroid therapy and improved patient safety.Material and Methods Ipilimumab/niv…